Showing results (91-100 of 122) with videos related to
Sort By:
Pageof 13
Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.Nature Medicine|January 17, 2024
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphomaFrederick L Locke, Simone Filosto, Justin Chou, et al.The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.Bone Marrow Transplantation|September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.Transplantation and Cellular Therapy|April 12, 2022
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular TherapyAmal Alseraihy, Eoin McGrath, Dietger Niederwieser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.Haematologica|October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.Transplantation and Cellular Therapy|April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group ReportKirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.Lupus|May 4, 2004
Autologous stem cell transplantation for systemic lupus erythematosusDavid Jayne, Jacob Passweg, Alberto Marmont, et al.The Lancet. Haematology|December 22, 2015
One million haemopoietic stem-cell transplants: a retrospective observational studyAlois Gratwohl, Marcelo C Pasquini, Mahmoud Aljurf, et al.Pageof 13